Thrombocytosis in rheumatoid arthritis

Area of Science:

• Rheumatology
• Hematology
• Immunology

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
• Platelet count variations, including thrombocytosis, are observed in RA patients.
• The relationship between thrombocytosis and RA severity, extra-articular manifestations, and coagulation status requires further elucidation.

Purpose of the Study:

• To investigate the association between thrombocytosis and rheumatoid arthritis disease severity.
• To explore the correlation between platelet count and hemoglobin levels in RA patients.
• To determine platelet and fibrinogen kinetics and their relationship with thrombocytosis in RA.

Main Methods:

• Patient cohort: 75 patients with rheumatoid arthritis (39 with thrombocytosis, 36 with normal platelet count).
• Correlation analysis: Assessing the relationship between platelet count, disease severity, and hemoglobin levels.
• Isotope labeling: Using 75Selenomethionine to determine platelet and fibrinogen survival and turnover rates.

Main Results:

• A significant positive correlation was found between platelet count and rheumatoid arthritis disease severity.
• An inverse correlation was observed between platelet count and hemoglobin levels.
• Patients with thrombocytosis exhibited decreased platelet survival and increased platelet turnover.
• Reduced fibrinogen survival and increased fibrinogen turnover were noted in patients with thrombocytosis and even in some with normal platelet counts, alongside detected fibrin degradation products.

Conclusions:

• Thrombocytosis is associated with more severe rheumatoid arthritis and may serve as a marker for disease activity.
• The findings suggest that thrombocytosis in RA is a compensatory increase in platelet production linked to active intravascular coagulation.
• Further research into the role of coagulation and platelet activation in RA pathogenesis is warranted.